Estimates Revisions Ernexa Therapeutics Inc.
Stocks
ERNA
US1140824079
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 4.430 USD | +4.24% |
|
+0.23% | -85.23% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ERNA Stock
- Consensus Ernexa Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
